Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05759806

Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Nephronyx LTD · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this interventional study is to evaluate the safety and functional performance of the Nephronyx System in patients with ADHF, presenting clinical signs of volume overload and compromised response to diuretics.

Conditions

Interventions

TypeNameDescription
DEVICENephronyx system (Perfuser)Temporary deployment of the Nephronyx system (Perfuser)

Timeline

Start date
2022-12-19
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2023-03-08
Last updated
2025-05-25

Locations

4 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT05759806. Inclusion in this directory is not an endorsement.